Short description
Ascenta Therapeutics, a clinical-stage biopharmaceutical company, focuses on the discovery and development of new medicines to treat cancer.
Description
Ascenta Therapeutics is a privately-held, clinical stage biopharmaceutical company dedicated to the discovery and development of new medicines to treat cancer. Ascenta's current focus is a portfolio of novel, orally-active, small molecule drugs that restore the natural potential for cancer cells to undergo cell death (apoptosis).
Last funding
Noaccess
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Malvern, Pennsylvania, United States, North America
Founded on
January 1, 2003
Non-profit?
No
Acquired?
No
Employees count
51-100
Revenue range
$1230 - 4560
Sign in for full access
Investors
Noaccess, Cannot Access, No Way, No Way, Cannot Access, Uh Ohhhh
Sign in for full access
Founders
Dajun Yang, Marc Lippman, Shaomeng Wang